Patrice P. Denefle
Keine laufenden Positionen mehr
Karriereverlauf von Patrice P. Denefle
Ehemalige bekannte Positionen von Patrice P. Denefle
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CENTOGENE N.V. | Technik-/Wissenschafts-/F&E-Leiter | 16.08.2021 | 01.07.2023 |
4P-Pharma | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Patrice P. Denefle
Université De Lille | Undergraduate Degree |
Statistik
International
Frankreich | 4 |
Deutschland | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 3 |
Undergraduate Degree | 1 |
Sektoral
Commercial Services | 3 |
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
CENTOGENE N.V. | Commercial Services |
Private Unternehmen | 2 |
---|---|
Genethon
Genethon BiotechnologyHealth Technology Genethon is a biotherapy research and development firm, which engages in the design, development, and production of gene therapy treatments for rare diseases. It specializes in neuromuscular diseases, immune system or blood disorders, eye disorders, and liver and nervous system diseases. The company was founded in 1990 and is headquartered in Evry, France. | Health Technology |
4P-Pharma | Commercial Services |
- Börse
- Insiders
- Patrice P. Denefle
- Erfahrung